1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow mivebresib: new trials by email Literature Review of mivebresib trials Research Report on mivebresib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis Mivebresib, Navitoclax, Ruxolitinib - Myelofibrosis (MF) | Phase 1 | Terminated | AbbVie | 1 | 2021-03-17 | 2023-08-29 |
| A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer ABBV-075, Venetoclax - Cancer, Breast Cancer | Phase 1 | Completed | AbbVie | 128 | 2015-04-14 | 2019-11-29 |
Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Primary Myelofibrosis (1) · Prostatic Neoplasms (1) · Small Cell Lung Carcinoma (1)
AbbVie (2)
United States (2) · South Africa (1) · South Korea (1)